MedTrace Logo

Food Effect Study of a Single Dose of ZD4054 (Zibotentan)

NCT00710047 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-11-15

No results posted yet for this study

Summary

The purpose of the study is to assess the effect of food on the pharmacokinetics of a 10 mg single oral dose of ZD4054 (Zibotentan)

Conditions

  • Healthy Volunteers

Interventions

DRUG

ZD4054

one single 10mg dose

Sponsors & Collaborators

Principal Investigators

  • Thomas Morris · AstraZeneca, Medical Science Director

  • David Wessels · Parexel

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00710047 on ClinicalTrials.gov